Journey Medical Corp logo

Journey Medical Corp (DERM)

Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
7. 16
+0.05
+0.7032%
$
195.95M Market Cap
- P/E Ratio
- Div Yield
103,100 Volume
- Eps
$ 7.11
Previous Close
Investors:
Add Transaction
Day Range
6.91 7.34
Year Range
4.31 9.55
Want to track DERM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

DERM closed today higher at $7.16, an increase of 0.7032% from yesterday's close, completing a monthly increase of 14.1946% or $0.89. Over the past 12 months, DERM stock lost -7.1336%.
DERM is not paying dividends to its shareholders.
The last earnings report, released on May 19, 2026, exceeded the consensus estimates by 0.03%. On average, the company has surpassed earnings expectations by 0.05%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

DERM Chart

People also search for

NEWEGG COMMERCE INC
$ 12.99
-6.748%
Soluna Holdings Inc. 9% Perpetual Preferred Stock
$ 9.5
+1.0638%
Hudson Technologies Inc.
$ 6.17
-2.2187%
MaxsMaking Inc.
$ 13
0%
Soluna Holdings Inc.
$ 1.13
+2.7273%
Journey Medical Corporation (DERM) Q1 2026 Earnings Call Transcript

Journey Medical Corporation (DERM) Q1 2026 Earnings Call Transcript

Journey Medical Corporation (DERM) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript

Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript

Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript

Seekingalpha | 3 months ago
Journey Medical Corporation (DERM) Q3 2025 Earnings Call Transcript

Journey Medical Corporation (DERM) Q3 2025 Earnings Call Transcript

Journey Medical Corporation ( DERM ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Jaclyn Jaffe - Senior Director of Corporate Operations Claude Maraoui - Founder, President, CEO & Director Joseph Benesch - CFO & Corporate Controller Ramsey Alloush - COO, General Counsel & Company Secretary Conference Call Participants Brandon Folkes - H.C. Wainwright & Co, LLC, Research Division Scott Henry - Alliance Global Partners, Research Division Thomas Flaten - Lake Street Capital Markets, LLC, Research Division Mayank Mamtani - B.

Seekingalpha | 8 months ago

Journey Medical Corp Investors

Name Quantity Cost Value Profit ($) Gain (%)
Joseph Castro
Joseph Castro Nuveen LLC
24,034 $151,837.4 $174,967.52 $23,130.12 15.23%
Alexandra Stickelman
Alexandra Stickelman Root Financial Partners, LLC
2 $9 $14.36 $5.36 59.56%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
4,002 $28,734 $28,274.13 -$459.87 -1.6%

Journey Medical Corp (DERM) FAQ

What is the stock price today?

The current price is $7.16.

On which exchange is it traded?

Journey Medical Corp is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is DERM.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 195.95M.

Has Journey Medical Corp ever had a stock split?

No, there has never been a stock split.

Journey Medical Corp Profile

Specialty Retail Industry
Consumer Discretionary Sector
Claude Maraoui CEO
NASDAQ (CM) Exchange
48115J109 CUSIP
US Country
58 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Journey Medical Corporation, initially known as Coronado Dermatology, Inc., is a healthcare enterprise that has dedicated its efforts towards the development and commercialization of pharmaceutical products specifically targeted at treating dermatological conditions. Its operational base is in the United States, with its headquarters situated in Scottsdale, Arizona. Journey Medical Corporation functions as a subsidiary of Fortress Biotech, Inc., and has been in operation since its incorporation in the year 2014. The company has carved out a niche for itself in the dermatology domain by offering an array of treatment solutions ranging from medicated cloths for hyperhidrosis to oral and topical medications for acne and rosacea, among others.

Products and Services

  • Qbrexza: This product is a medicated cloth towelette designed for the treatment of primary axillary hyperhidrosis, which is characterized by excessive underarm sweating.
  • Accutane: An oral isotretinoin medication, Accutane is utilized for the treatment of severe recalcitrant nodular acne, providing a potent solution for those suffering from this challenging condition.
  • Amzeeq: As a topical formulation of minocycline, Amzeeq is indicated for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris, offering a topical approach to acne management.
  • Zilxi: This topical minocycline treatment is tailored for the management of inflammatory lesions of rosacea, providing a specific solution for this common skin condition.
  • Exelderm: Available as both a cream and a solution, Exelderm is an antifungal medication intended for topical application, effectively treating a variety of fungal infections.
  • Targadox: Targadox is an oral doxycycline medication recommended as an adjunctive therapy for severe acne, aiding in the overall treatment regimen for those battling severe forms of acne.
  • Luxamend: A water-based emulsion, Luxamend is formulated to provide a moist healing environment for superficial wounds, minor cuts or scrapes, dermal ulcers, donor sites, first- and second-degree burns, including sunburns, and radiation dermatitis, catering to a wide range of skin healing needs.
  • Sulconazole Nitrate Cream and Solution: Indicated for the treatment of tinea cruris, tinea corporis, and tinea versicolor, these products offer an effective solution for these fungal skin conditions.
  • Doxycycline Hyclate Tablets: As an adjunctive therapy for severe acne, these tablets provide an oral treatment option to assist in the control and management of acne.

Contact Information

Address: 9237 East Via de Ventura Boulevard
Phone: 480 434 6670